Orexo AB (publ) (ORXOF)
OTCMKTS · Delayed Price · Currency is USD
2.900
+0.350 (13.73%)
At close: Sep 26, 2025
Orexo AB Employees
Orexo AB had 110 employees as of December 31, 2024. The number of employees decreased by 6 or -5.17% compared to the previous year.
Employees
110
Change (1Y)
-6
Growth (1Y)
-5.17%
Revenue / Employee
$554,608
Profits / Employee
-$205,924
Market Cap
102.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 110 | -6 | -5.17% |
| Dec 31, 2023 | 116 | -10 | -7.94% |
| Dec 31, 2022 | 126 | 7 | 5.88% |
| Dec 31, 2021 | 119 | -18 | -13.14% |
| Dec 31, 2020 | 137 | 10 | 7.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |